Stantec, a large publicly traded design and consulting company, is acquiring Santa Barbara-based engineering firm Penfield & Smith. Terms of the deal, expected to close in October, were not disclosed. Penfield & Smith has regional offices in Santa Barbara, Camarillo and Santa Maria. The company had revenue of $16 million last year, according to Business Read More →
Amgen became the first drugmaker to seek U.S. regulatory approval for a new class of cholesterol-lowering treatments after it submitted an application to the Food and Drug Administration on Thursday for evolocumab. Thousand Oaks-based Amgen said the drug works by blocking a naturally occurring protein called PCSK9 that prevents the liver from removing LDL cholesterol, Read More →
By Editorial Board / Friday, August 1st, 2014 / Editorials, Opinion / Comments Off on Editorial: Large employers loosen grip on Ventura County
Half-a-dozen years ago, East Ventura County’s economy was heavily dependent on two very large employers: subprime lending giant Countrywide Financial Corp. and biotech behemoth Amgen.
Thousand Oaks-based Amgen will cut staff at its Conejo Valley headquarters and consolidate into fewer buildings as part of a company-wide restructuring plan that will eliminate between 2,400 and 2,900 jobs and shutter facilities in Colorado and Washington. Amgen said the moves are designed to reduce operating expenses by $700 million by 2016, money that Read More →
While other companies look to the skies for drone business opportunities, Teledyne Technologies is looking to the seas. The Thousand Oaks-based conglomerate has been investing in so-called autonomous underwater vehicles that are used by oceanographers, oil and gas companies and for military missions. On July 2, Teledyne invested in a San Diego company called Ocean Read More →
Shares of Thousand Oaks-based energy crop firm Ceres were up 8 percent in midday trading on news that the company inked a deal to monetize its genome viewing software through a deal with Bayer CropScience.
Amgen has hired David Meline, formerly with industrial conglomerate 3M Co., as its new chief financial officer. At 3M, Meline was responsible for the finances of a Minnesota-based company with more than $30 billion in worldwide revenues. Amgen, the world’s largest biotechnology firm, had profits of $5 billion in 2013, a 17 percent increase from Read More →